Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Capital Expenditures (2022 - 2025)

Envoy Medical's Capital Expenditures history spans 4 years, with the latest figure at $123000.0 for Q4 2025.

  • Quarterly results put Capital Expenditures at $123000.0 for Q4 2025, up 123.03% from a year ago — trailing twelve months through Dec 2025 was $179000.0 (down 81.73% YoY), and the annual figure for FY2025 was $179000.0, down 81.73%.
  • Capital Expenditures for Q4 2025 was $123000.0 at Envoy Medical, up from $49000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.2 million in Q3 2024 to a low of -$534000.0 in Q4 2024.
  • The 4-year median for Capital Expenditures is $49000.0 (2025), against an average of $104076.9.
  • Peak annual rise in Capital Expenditures hit 2154.55% in 2024, while the deepest fall reached 2642.86% in 2024.
  • Year by year, Capital Expenditures stood at $41000.0 in 2022, then tumbled by 48.78% to $21000.0 in 2023, then crashed by 2642.86% to -$534000.0 in 2024, then skyrocketed by 123.03% to $123000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $123000.0, $49000.0, and $1000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.